In the U.S. today, it’s estimated that more than five million adult men have low testosterone. Symptoms of this condition include low libido, decreased enjoyment of life, decreased ability to concentrate and decreased sports performance. Testosterone deficiency is highly associated with multiple disease states including obesity, diabetes, hypertension, high cholesterol and asthma.
Find A DoctorLow testosterone is diagnosed through a blood test where physicians look for the level of testosterone and sex hormone binding globulin (SHBG), a protein that tightly binds testosterone and makes it unavailable for use by the target organ.
Testosterone replacement therapy (TRT) – Testosterone replacement therapy (TRT) can be administered in many forms. Most patients will begin their treatment process with transdermal (TD) application routes. The most common form is a gel that is applied to clean, dry skin every day at the same time, usually after a man gets out of the shower. TD application is easy, well tolerated and allows for excellent absorption of testosterone and an even delivery of the hormone on a daily basis. There are minimal side effects. Some men will have a mild skin irritation while others may see an increase in their hematocrit, which will then need to be monitored.
Injection therapy is another effective option. This involves the injection of testosterone on either a bi-monthly or weekly basis. The injections will give a high concentration of testosterone for the first few days and will decline to a low level after 10-12 days. It is a very effective therapy, but it does require the patient or patient’s partner to learn how to inject or make frequent office visits.
Once starting TRT, patients should notice improved energy levels, exercise tolerance, libido and erectile function within the first few weeks of therapy. Optimal results will be achieved within about three to six months. Center for Men’s Health patients will return to the TUCC four to six weeks after their first dosing to ensure adequate serum levels. Once a good regimen has been established, blood work will be checked periodically.
Every year for the past nine years the physicians and staff of The Urology Center of Colorado (TUCC) come together and celebrate survivorship with our patients, family and friends…and some classic car enthusiasts, from around the Denver region. “This is a very special event for TUCC and our patients,” says Martha Ruschival, Executive Director of
Read More
TUCC physician Lawrence Karsh, M.D., served as a lead investigator in this clinical trial which investigated the first human experience with the Transurethral Suprapubic endo-Cystostomy (T-SPeC®) device, a novel disposable device used for introducing a suprapubic catheter via a retrourethral (inside-to-out) approach similar to the Lowsley technique. The results of this investigation were published in
Read More
TUCC physician Lawrence Karsh, M.D., was a lead principal investigator in this Phase III, double-blind, randomised, placebo-controlled study of men with non-metastatic castration-resistant prostate cancer at high risk of bone metastasis published in The Lancet in January 2012. Read Article
Read More